webinar register page

Webinar banner
Medicare Approach to Sepsis and Quality of Care: What You Need to Know
Medicare increasingly views sepsis as one of the most important areas of health care policy, and this is more acute in 2020, since many COVID-19 patients die in septic shock. Medicare uses a complex quality measure, called "SEP-1," which presents challenges for hospitals and has had mixed responses in the peer-reviewed literature. Meanwhile, discussion is turning other measures of care quality and expanded use of biomarkers to guide care in sepsis. This webinar will overview the prevalence of sepsis in the Medicare population, review the SEP-1 measure, and discuss new trends in quality measures in sepsis.

Bruce Quinn, MD, PhD
Principal, Bruce Quinn Associates, LLC
*** Bio below.

Sepsis Alliance gratefully acknowledges the support provided for this sponsor innovation webinar by Thermo Fisher Scientific.

Aug 26, 2020 02:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Bruce Quinn, MD, PhD
Principal @Bruce Quinn Associates, LLC
Dr. Bruce Quinn is an expert on health reform, innovation, and Medicare policy. A pathologist by training, he has worked on a wide range of federal health policy issues ranging from biopharma to genomics. He has served as a full-time faculty member at both NYU and Northwestern University schools of medicine. After serving as a physician executive with Medicare, he served as a sciences strategy consultant serving clients of two major law firms, Foley Hoag LLP and Faegre Baker Daniels LLP. Since 2017, Dr. Quinn manages his own medtech and biopharma consulting practice based in Los Angeles and San Francisco. His blog, Discoveries in Health Policy, current logs over 100,000 hits per year. Dr. Quinn has helped leading companies in both medical device and biopharma negotiate with CMS on important policy issues including drug innovation, antibiotics policy, and genomics.